Kineticos continues to host live and relevant panel discussions via Zoom considering relevant trends, inflection points, and others issues influencing life sciences markets, including COVID-19, and how they directly and indirectly impact companies looking at Corporate Strategy, Business Development and Licensing, and Commercial Execution implications.


Watch: The 2021 Q1 Biopharma Confidence Index Panel Discussion

Kineticos is excited to have hosted a panel discussion with Kineticos Experts and Industry Veterans on the 2021 Q1 BCI. Our experts discuss what the data means, how things have changed since COVID started and how the future looks as more and more get vaccinated.

Click here to watch.


Watch: “Increasing Patient Engagement Through Decentralized Clinical Research”

Our December panel discussion is about “Increasing Patient Engagement Through Decentralized Clinical Research.” Our group of expert panelists from Spencer Health Solutions, Worldwide Clinical Trials, TrialCard, and Savvy Cooperative dive deep into direct-to-patient clinical trials (decentralized trials). This discussion is approximately 60 minutes long.

Click here to watch.


Watch: “The State of Gene Editing Technologies and CRISPR”

Join the conversation with our panel of Life Sciences industry experts as they discuss the current state of gene editing technologies and CRISPR. This discussion is approximately 60 minutes long.

Click here to watch.


Watch Part 7: “Building a CDMO Facility During COVID”

Join the conversation with our panel of Life Sciences Industry Leaders from Arranta Bio, DCBA, Oelrich Construction, DPS Global, and AEI Affiliated Engineers as they discuss the topic “Building a CDMO Facility During COVID.”

Click here to watch.


Watch Special Edition Panel: “The Impact of the Astronaut Scholarship Foundation on the Life Sciences Industry”

Join the conversation with our panel of Life Sciences Industry Leaders, who are ASF alumni, as they discuss the “Impact of the Astronaut Scholarship Foundation on the Life Sciences Industry.” The ASF’s mission is to aid the United States in retaining its world leadership in technology and innovation by supporting the very best and brightest scholars in science, technology, engineering and mathematics while commemorating the legacy of America’s pioneering astronauts.

Click here to watch.


Watch Part 6: Biotech Licensing Strategies in a COVID-19 World”

Join the conversation with our panel of Life Sciences Industry Leaders from Biosion, ASC Therapeutics, KnowBio, and Kineticos as they discuss the topic “Biotech Licensing Strategies in a COVID-19 World.”

Click here to watch.


Watch Part 5: “Diagnostics Strategy and Innovation in a COVID World”

Join the conversation with our panel of Life Sciences Industry Leaders from Roche Diagnostics, LabCorp, NeoGenomics, and Kineticos as they discuss the topic “Diagnostics Strategy and Innovation in a COVID World”

Click here to watch.


Watch Part 4: “COVID-19: Should You Take Your Technology Platform Where the Action is?”

Join the conversation with our panel of Life Sciences Industry Leaders from OpGen, Mammoth Biosciences, Pneumagen, Cepheid, and Kineticos as they discuss the question “Should You Take Your Technology Platform Where the Action is?”

Click here to watch.


Watch Part 3: “CDMO Strategy in a COVID-19 World”

Join the conversation with our panel of Life Science Industry Leaders from Arranta Bio, Recipharm, Aji Bio-Pharma Services, and Kineticos as they discuss CDMO challenges, opportunities and strategies in a COVID-19 World.

Click here to watch.


Watch Part 2: “How are Biotechs Pivoting During COVID-19?”

Join our panel of industry leaders from Atox Bio, Experious Consulting, Jerry H. Hodge School of Pharmacy, Worldwide Clinical Trials, and Kineticos as they discuss the impact of COVID-19 on Corporate Strategy, specifically how biotechs are pivoting during this pandemic.

Click here to watch.


Watch Part 1: “What are Post COVID-19 Implications to Corporate Strategy?”

Join our panel of industry leaders from GeneCentric, Adjuvance Technologies, Locus Biosciences, and Kineticos as they look at Post COVID-19 implications to Corporate Strategy, specifically R&D and approaches to Market Opportunities, Portfolio Strategy, and Clinical Roadmaps.

Click here to watch.